Back to News
Market Impact: 0.12
XORTX Slips 10% As Investor Relations Program Is Terminated And Postponed
Source: Nasdaq
Company FundamentalsCorporate Guidance & Outlook
XORTX Therapeutics (XRTX) announced it will terminate and postpone its previously disclosed investor relations and marketing agreement with IR Agency LLC. The move suggests a near-term disruption to planned communications/marketing efforts, with limited immediate financial detail provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
XRTX-0.45
More News
- ‘If nothing is done, it’s almost inevitable’: Ukraine’s Yuriy Ryzhenkov on why steelmaking is on the brink of collapse as Russian bombing intensifies
- Why is LG Innotek stock plunging today?
- TotalEnergies, KKR expand U.S. solar venture with 700 MW addition
- TSMC expected to report sixth straight quarter of record profit thanks to AI boom
- Vår Energi cuts 2026 output forecast; Q3 production at 369,000 boepd
- CXMT: How big is its market threat to Samsung, SK Hynix and Micron?